We have studied the association between CYP2C19 and CYP2D6 gene variants and the treatment outcomes in children and adolescents, young adults, and adults with depression who were using (es)citalopram, sertraline, or fluoxetine. The gene discussed is CYP2D6; the disease is major depressive disorder.